Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32369
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDickmann, Catherine G Fitzgerald-
dc.contributor.authorMcDonald, Alexander F-
dc.contributor.authorHuynh, Nhi-
dc.contributor.authorRigopoulos, Angela-
dc.contributor.authorLiu, Zhanqi-
dc.contributor.authorGuo, Nancy-
dc.contributor.authorOsellame, Laura D-
dc.contributor.authorGorman, Michael A-
dc.contributor.authorParker, Michael W-
dc.contributor.authorGan, Hui K-
dc.contributor.authorScott, Andrew M-
dc.contributor.authorAckermann, Uwe-
dc.contributor.authorBurvenich, Ingrid J G-
dc.contributor.authorWhite, Jonathan M-
dc.date2023-
dc.date.accessioned2023-03-22T02:18:55Z-
dc.date.available2023-03-22T02:18:55Z-
dc.date.issued2023-03-09-
dc.identifier.citationChemical communications (Cambridge, England) 2023; 59(21): 3126-3129en_US
dc.identifier.issn1364-548X-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32369-
dc.description.abstractBromodomain and extraterminal (BET) proteins, a family of epigenetic regulators, have emerged as important oncology drug targets. BET proteins have not been targeted for molecular imaging of cancer. Here, we report the development of a novel molecule radiolabelled with positron emitting fluorine-18, [18F]BiPET-2, and its in vitro and preclinical evaluation in glioblastoma models.en_US
dc.language.isoeng-
dc.titleBromodomain and extraterminal protein-targeted probe enables tumour visualisation in vivo using positron emission tomography.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleChemical communications (Cambridge, England)en_US
dc.identifier.affiliationBio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia.en_US
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen_US
dc.identifier.affiliationMolecular Imaging and Therapyen_US
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Australia.en_US
dc.identifier.doi10.1039/d2cc04813ben_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-8829-5354en_US
dc.identifier.orcid0000-0001-5261-8118en_US
dc.identifier.orcid0000-0001-6174-3797en_US
dc.identifier.orcid0000-0003-3438-8245en_US
dc.identifier.orcid0000-0002-3101-1138en_US
dc.identifier.orcid0000-0001-7319-8546en_US
dc.identifier.orcid0000-0002-6656-295Xen_US
dc.identifier.orcid0000-0001-9259-2258en_US
dc.identifier.orcid0000-0001-8384-2403en_US
dc.identifier.orcid0000-0002-0707-6257en_US
dc.identifier.pubmedid36809538-
dc.description.volume59-
dc.description.issue21-
dc.description.startpage3126-
dc.description.endpage3129-
dc.subject.meshtermssecondaryPositron-Emission Tomography/methods-
dc.subject.meshtermssecondaryGlioblastoma/diagnostic imaging-
local.name.researcherAckermann, Uwe
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptMolecular Imaging and Therapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

100
checked on Nov 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.